Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email

Lynne Wagner

A professional headshot of Dr. Lynne Wagner, a White woman with a light skin tone and blonde hair, wearing a black blazer and blue top while smiling at the camera and standing in her office.

Dr. Lynne Wagner believes improving how adolescent and young adult patient-reported outcomes are captured and shared is a priority and could help personalize treatments for these patients.

Credit: National Cancer Institute

  • Codirector, Cancer Control and Outcomes Program, ECOG-ACRIN Cancer Research Group
  • Multiple-Principal Investigator, ECOG-ACRIN NCI Community Oncology Research Program Research Base
  • Professor, Social Sciences and Health Policy, Wake Forest University School of Medicine

Dr. Lynne Wagner has a passion for learning from patients and designing cancer clinical trials for adolescents and young adults (AYAs) that ensure their voices are heard. AYAs are underrepresented in patient-reported outcome data, but Lynne wants to change that. With CCDI funding, ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) is conducting the EAQ202 trial to study whether letting AYAs choose what quality of life aspects they want to discuss improves how patient-reported outcomes are captured and shared.

She believes hearing from patients directly about their experiences is crucial, and that data related to, for instance, anxiety, depression, fertility, employment, financial toxicity, and social isolation, can break down communication barriers between patients and providers and help personalize interventions. “The strength and resiliency of AYA survivors is always inspiring,” said Lynne. “We want to ensure we’re working with them to learn from this difficult life experience, to improve health for all patients.”

Sign up to get stories like this and CCDI updates in your inbox

  • Posted:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Lynne Wagner was originally published by the National Cancer Institute.”

Email